Loading clinical trials...
Loading clinical trials...
Detecting memory problems early is crucial for treating conditions like Mild Cognitive Impairment (MCI), which often leads to dementia. Currently, doctors use tests in clinics to check for these issue...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alberta
NCT07571161 · Alzheimer Disease
NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
NCT06347315 · Mild Cognitive Impairment
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT06937229 · Alzheimer Disease, Agitation
Alzheimer Society of Alberta and Northwest Territories
Edmonton, Alberta
CapitalCare Corporate Services
Edmonton, Alberta
Edmonton Life Long Learners
Edmonton, Alberta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions